BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16265778)

  • 1. Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids.
    Eivindson M; Grønbaek H; Nielsen JN; Frystyk J; Flyvbjerg A; Jørgensen L; Vind I; Munkholm P; Jensen S; Brandslund I; Hey H
    Scand J Gastroenterol; 2005 Oct; 40(10):1214-21. PubMed ID: 16265778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients.
    Haugaard SB; Andersen O; Hansen BR; Orskov H; Andersen UB; Madsbad S; Iversen J; Flyvbjerg A
    Metabolism; 2004 Dec; 53(12):1565-73. PubMed ID: 15562401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids.
    Nielsen AA; Jørgensen LG; Nielsen JN; Eivindson M; Grønbaek H; Vind I; Hougaard DM; Skogstrand K; Jensen S; Munkholm P; Brandslund I; Hey H
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1121-8. PubMed ID: 16305726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease.
    Beattie RM; Camacho-Hübner C; Wacharasindhu S; Cotterill AM; Walker-Smith JA; Savage MO
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):483-9. PubMed ID: 9876346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone.
    Nielsen AA; Nielsen JN; Grønbaek H; Eivindson M; Vind I; Munkholm P; Brandslund I; Hey H
    Digestion; 2007; 75(1):10-6. PubMed ID: 17429201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
    Eivindson M; Nielsen JN; Grønbaek H; Flyvbjerg A; Hey H
    Horm Res; 2005; 64(1):9-15. PubMed ID: 16088202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation.
    Argente J; Caballo N; Barrios V; Muñoz MT; Pozo J; Chowen JA; Morandé G; Hernández M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2084-92. PubMed ID: 9215276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal women.
    Kassem M; Brixen K; Mosekilde L; Blum WF; Flyvbjerg A
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):747-56. PubMed ID: 10209562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone.
    Lee PD; Durham SK; Martinez V; Vasconez O; Powell DR; Guevara-Aguirre J
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2266-74. PubMed ID: 9215305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin-like growth factor axis in children with inflammatory bowel disease.
    Corkins MR; Gohil AD; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):228-34. PubMed ID: 12548059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
    Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
    Gargosky SE; Nanto-Salonen K; Tapanainen P; Rosenfeld RG
    J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment.
    Grønbek H; Thøgersen T; Frystyk J; Vilstrup H; Flyvbjerg A; Dahlerup JF
    Am J Gastroenterol; 2002 Mar; 97(3):673-8. PubMed ID: 11922563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction.
    Argente J; Caballo N; Barrios V; Pozo J; Muñoz MT; Chowen JA; Hernández M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2076-83. PubMed ID: 9215275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease.
    Eivindson M; Grønbaek H; Skogstrand K; Thorsen P; Frystyk J; Flyvbjerg A; Dahlerup JF
    Scand J Gastroenterol; 2007 Apr; 42(4):464-70. PubMed ID: 17454856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of GH stimulation on fasting and prandial metabolism and plasma IGFs and IGF-binding proteins in lean and obese sheep.
    McCann JP; Loo SC; Aalseth DL; Abribat T
    J Endocrinol; 1997 Aug; 154(2):329-46. PubMed ID: 9291844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.